CVS Health Other Non-Current Liabilities 2010-2024 | CVS
CVS Health other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- CVS Health other non-current liabilities for the quarter ending December 31, 2024 were $13.644B, a 8.55% decline year-over-year.
- CVS Health other non-current liabilities for 2024 were $13.644B, a 8.55% decline from 2023.
- CVS Health other non-current liabilities for 2023 were $14.92B, a 5.53% decline from 2022.
- CVS Health other non-current liabilities for 2022 were $15.793B, a 17.92% increase from 2021.
| CVS Health Annual Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $13,644 |
| 2023 | $14,920 |
| 2022 | $15,793 |
| 2021 | $13,393 |
| 2020 | $14,239 |
| 2019 | $14,057 |
| 2018 | $14,783 |
| 2017 | $1,611 |
| 2016 | $1,549 |
| 2015 | $1,542 |
| 2014 | $1,531 |
| 2013 | $1,421 |
| 2012 | $1,501 |
| 2011 | $1,445 |
| 2010 | $1,058 |
| 2009 | $1,102 |
| CVS Health Quarterly Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2024-12-31 | $13,644 |
| 2024-09-30 | $13,980 |
| 2024-06-30 | $13,752 |
| 2024-03-31 | $14,654 |
| 2023-12-31 | $14,920 |
| 2023-09-30 | $14,770 |
| 2023-06-30 | $15,247 |
| 2023-03-31 | $15,580 |
| 2022-12-31 | $15,793 |
| 2022-09-30 | $16,262 |
| 2022-06-30 | $12,567 |
| 2022-03-31 | $13,275 |
| 2021-12-31 | $13,393 |
| 2021-09-30 | $13,947 |
| 2021-06-30 | $13,928 |
| 2021-03-31 | $13,871 |
| 2020-12-31 | $14,239 |
| 2020-09-30 | $14,448 |
| 2020-06-30 | $14,217 |
| 2020-03-31 | $14,010 |
| 2019-12-31 | $14,057 |
| 2019-09-30 | $14,325 |
| 2019-06-30 | $14,764 |
| 2019-03-31 | $14,742 |
| 2018-12-31 | $14,783 |
| 2018-09-30 | $1,625 |
| 2018-06-30 | $1,563 |
| 2018-03-31 | $1,604 |
| 2017-12-31 | $1,611 |
| 2017-09-30 | $1,644 |
| 2017-06-30 | $1,689 |
| 2017-03-31 | $1,704 |
| 2016-12-31 | $1,549 |
| 2016-09-30 | $1,597 |
| 2016-06-30 | $1,553 |
| 2016-03-31 | $1,567 |
| 2015-12-31 | $1,542 |
| 2015-09-30 | $1,528 |
| 2015-06-30 | $1,490 |
| 2015-03-31 | $1,513 |
| 2014-12-31 | $1,531 |
| 2014-09-30 | $1,494 |
| 2014-06-30 | $1,489 |
| 2014-03-31 | $1,499 |
| 2013-12-31 | $1,421 |
| 2013-09-30 | $1,563 |
| 2013-06-30 | $1,534 |
| 2013-03-31 | $1,538 |
| 2012-12-31 | $1,501 |
| 2012-09-30 | $1,513 |
| 2012-06-30 | $1,438 |
| 2012-03-31 | $1,431 |
| 2011-12-31 | $1,445 |
| 2011-09-30 | $1,348 |
| 2011-06-30 | $1,343 |
| 2011-03-31 | $1,032 |
| 2010-12-31 | $1,058 |
| 2010-09-30 | $1,061 |
| 2010-06-30 | $1,070 |
| 2010-03-31 | $1,108 |
| 2009-12-31 | $1,102 |
| 2009-09-30 | $1,152 |
| 2009-06-30 | $1,108 |
| 2009-03-31 | $1,108 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $84.718B | $372.809B |
| CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.784B | 25.47 |
| Elevance Health (ELV) | United States | $91.409B | 11.80 |
| Cencora (COR) | United States | $54.879B | 19.08 |
| DiDi Global (DIDIY) | China | $20.661B | 31.36 |
| Natera (NTRA) | United States | $20.542B | 0.00 |
| BioMerieux (BMXMF) | France | $15.263B | 0.00 |
| Solventum (SOLV) | United States | $12.150B | 12.86 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.973B | 0.00 |
| Doximity (DOCS) | United States | $11.050B | 57.47 |
| CochLear (CHEOY) | Australia | $10.944B | 0.00 |
| ICON (ICLR) | Ireland | $10.818B | 10.06 |
| Revvity (RVTY) | United States | $10.756B | 18.51 |
| Viatris (VTRS) | United States | $10.293B | 3.54 |
| Medpace Holdings (MEDP) | United States | $8.508B | 22.60 |
| Sonic Healthcare (SKHHY) | Australia | $8.280B | 0.00 |
| Avantor (AVTR) | United States | $8.191B | 11.90 |
| HealthEquity (HQY) | United States | $7.819B | 38.47 |
| Charles River Laboratories (CRL) | United States | $6.817B | 13.36 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 26.21 |
| Bausch + Lomb (BLCO) | Canada | $3.982B | 23.48 |
| BrightSpring Health Services (BTSG) | United States | $3.976B | 36.81 |
| Sotera Health (SHC) | United States | $3.727B | 21.18 |
| Alignment Healthcare (ALHC) | United States | $2.991B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.841B | 32.59 |
| Concentras Parent (CON) | United States | $2.743B | 15.85 |
| Organon (OGN) | United States | $2.264B | 2.41 |
| Premier (PINC) | United States | $2.106B | 14.42 |
| Ardent Health Partners (ARDT) | United States | $2.077B | 8.85 |
| Progyny (PGNY) | United States | $1.815B | 39.98 |
| GeneDx Holdings (WGS) | United States | $1.687B | 64.99 |
| GoodRx Holdings (GDRX) | United States | $1.657B | 30.86 |
| PACS (PACS) | United States | $1.590B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.248B | 9.50 |
| Teladoc Health (TDOC) | United States | $1.247B | 0.00 |
| Agilon Health (AGL) | United States | $1.196B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.978B | 0.00 | |
| CareDx (CDNA) | United States | $0.855B | 13.36 |
| AMN Healthcare Services Inc (AMN) | United States | $0.840B | 7.89 |
| Embecta (EMBC) | United States | $0.696B | 4.71 |
| QDM (QDMI) | Hong Kong, SAR China | $0.690B | 0.00 |
| Nutex Health (NUTX) | United States | $0.667B | 13.08 |
| Enhabit (EHAB) | United States | $0.521B | 42.83 |
| Auna S.A (AUNA) | Luxembourg | $0.508B | 13.45 |
| InnovAge Holding (INNV) | United States | $0.491B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.466B | 0.00 |
| LifeMD (LFMD) | United States | $0.375B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.352B | 0.00 |
| SBC Medicals (SBC) | United States | $0.345B | 0.00 |
| Beauty Health (SKIN) | United States | $0.234B | 0.00 |
| Oncology Institute (TOI) | United States | $0.212B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
| DocGo (DCGO) | United States | $0.143B | 23.33 |
| Basel Medical Group (BMGL) | Singapore | $0.088B | 0.00 |
| So-Young (SY) | China | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.084B | 0.00 |
| OncoCyte (OCX) | United States | $0.082B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.076B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Biodesix (BDSX) | United States | $0.054B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.029B | 0.00 |
| KindlyMD (KDLY) | United States | $0.023B | 0.00 |
| ModivCare (MODV) | United States | $0.017B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |